陈世清, 魏倩雯, & 王菁菁. (2023). 程序性死亡受体1抑制剂相关 1型糖尿病的临床特点分析. Chinese Journal of Diabetes Mellitus, 15(10), 972. https://doi.org/10.3760/cma.j.cn115791-20230628-00298
Chicago Style (17th ed.) Citation陈世清, 魏倩雯, and 王菁菁. "程序性死亡受体1抑制剂相关 1型糖尿病的临床特点分析." Chinese Journal of Diabetes Mellitus 15, no. 10 (2023): 972. https://doi.org/10.3760/cma.j.cn115791-20230628-00298.
MLA (9th ed.) Citation陈世清, et al. "程序性死亡受体1抑制剂相关 1型糖尿病的临床特点分析." Chinese Journal of Diabetes Mellitus, vol. 15, no. 10, 2023, p. 972, https://doi.org/10.3760/cma.j.cn115791-20230628-00298.
Warning: These citations may not always be 100% accurate.
